Showing results (231-240 of 291) with videos related to
Sort By:
Pageof 30
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 19, 2021
Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavirFumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, et al.Journal of Gastroenterology|October 5, 2016
Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogsFumitaka Suzuki, Yoshiyuki Suzuki, Tetsuya Hosaka, et al.Journal of Medical Virology|October 12, 2002
Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in JapanMariko Kobayashi, Yasuji Arase, Kenji Ikeda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2020
Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearanceFumitaka Suzuki, Tetsuya Hosaka, Masayasu Imaizumi, et al.Journal of Medical Virology|March 22, 2005
Persistence of acute infection with hepatitis B virus genotype A and treatment in JapanYoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, et al.Journal of Medical Virology|October 14, 2003
Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapyNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.Internal Medicine (Tokyo, Japan)|June 11, 2019
Role of NS5A-L31/Y93 Double Wild-type in Failure of Glecaprevir/Pibrentasvir Double Therapy in Two Patients with a History of Direct-acting Antiviral Agent Failure: An Ultra-deep Sequencing AnalysisTomoya Sano, Norio Akuta, Fumitaka Suzuki, et al.Journal of Medical Virology|January 19, 2006
Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutantsFumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, et al.Intervirology|July 19, 2005
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.Journal of Gastroenterology and Hepatology|June 16, 2010
Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patientsFumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, et al.Pageof 30